ArticleNPJ breast cancer2026

Neoadjuvant pembrolizumab plus chemotherapy in germline BRCA-mutated early triple-negative breast cancer: a multicenter real-world cohort.

Monique Celeste Tavares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.